Article
Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic…
ClinicoEconomics and Outcomes Research · 2023 · Lachaine J, Charron JN, Gregoire JC, Hegele RA, Leiter LA
Key facts
| Title | Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada |
|---|---|
| First author | Lachaine J, Charron JN, Gregoire JC, Hegele RA, Leiter LA |
| Journal | ClinicoEconomics and Outcomes Research |
| Published | Apr 20, 2023 |
| DOI | 10.2147/CEOR.S377935 |
| Devices mentioned | K791153 |
| Product codes mentioned | JAK |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1